-
Hinge Bio Presents Preclinical Data from its GEM-DIMER Program Targeting B Cell Depletion at the American Association for Cancer Research (AACR) Annual Meeting 2024
08 Apr 2024 19:29 GMT
… Receptors for T cell therapy (Cell Genesys, Inc.), and germline-modified mice …
-
Kelonia Therapeutics Appoints Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to Board of Directors
28 Mar 2024 11:21 GMT
… . Hege began her career at Cell Genesys Inc., where she spent 14 …
-
KaliVir Immunotherapeutics Appoints James M. Burke, M.D., as Chief Medical Officer
21 Feb 2024 13:09 GMT
… . He started his career at Cell Genesys, spearheading early gene and immunotherapy …
-
Ins and Outs: C-suite additions at CDMOs
02 Nov 2023 16:01 GMT
… Novartis, Atara, Shire, Gilead and Cell Genesys.
Gerard Fleury, appointed a financial …
-
Matica Bio Welcomes Four Life Sciences Visionaries as Members of Advisory Board
17 Oct 2023 21:47 GMT
… Novartis, Atara, Shire, Gilead and Cell Genesys will assume the role of …
-
B.C.-founded biologics developer Tentarix raises US$35-million after securing Gilead deal
06 Sep 2023 11:55 GMT
… the original scientific team at Cell Genesys Inc. that developed the first …
-
Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer
31 May 2023 08:37 GMT
… cell therapy/CAR-T (Cell Genesys). Dr. Capon also holds patents …
-
Adaptimmune Announces Changes to Board of Directors
17 Feb 2023 04:26 GMT
… , she began her career at Cell Genesys Inc. where she spent 14 …
-
Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development
03 Feb 2023 13:18 GMT
… held at UbiVac, Inc. and Cell Genesys, Inc. Dr. Aung earned her …
-
Cancer Gene Therapy Market, 2032 - ResearchAndMarkets.com
26 Jan 2023 15:04 GMT
… AB
Amgen
Bristol-Myers Squibb
Cell Genesys Inc.
Adaptimmune Therapeutics plc.
Achieve …